Correction: Structure-Based Analysis of A19D, a Variant of Transthyretin Involved in Familial Amyloid Cardiomyopathy

Correction: Structure-Based Analysis of A19D, a Variant of Transthyretin Involved in Familial Amyloid Cardiomyopathy

Show other versions (1)

Bibliographic Details
Main Authors:	Priscila Ferreira, Oliveira Sant'Anna, Nathalia Varejão, Cinthia Lima, Shenia Novis, Renata V. Barbosa, Concy M. Caldeira, Franklin D. Rumjanek, Salvador Ventura, Marcia W. Cruz, Debora Foguel
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2013-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3876948/?tool=EBI

Similar Items

Structure-based analysis of A19D, a variant of transthyretin involved in familial amyloid cardiomyopathy.
by: Priscila Ferreira, et al.
Published: (2013-01-01)

Correction: Structure-Based Analysis of A19D, a Variant of Transthyretin Involved in Familial Amyloid Cardiomyopathy.
by: Priscila Ferreira, et al.
Published: (2013-01-01)

Diagnosis of Transthyretin Amyloid Cardiomyopathy
by: Adam S. Hafeez, et al.
Published: (2020-04-01)

Speckle Tracking and Transthyretin Amyloid Cardiomyopathy
by: Alexandre Marins Rocha, et al.

Extrapolation of Survival Benefits in Patients with Transthyretin Amyloid Cardiomyopathy Receiving Tafamidis: Analysis of the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial
by: Benjamin Li, et al.
Published: (2020-06-01)

Best Practices for Prognostic Evaluation of a Patient With Transthyretin Amyloid Cardiomyopathy
by: Kent Y. Feng, MD, et al.
Published: (2019-12-01)

Clinical characteristics and prognosis of Chinese patients with hereditary transthyretin amyloid cardiomyopathy
by: Shan He, et al.
Published: (2019-11-01)

False‐positive bone scintigraphy denoting transthyretin amyloid in elderly hypertrophic cardiomyopathy
by: Cristina Chimenti, et al.
Published: (2021-08-01)

Estimating the Prevalence of Transthyretin Amyloid Cardiomyopathy in a Large In-Hospital Database in Japan
by: Ian Winburn, et al.
Published: (2019-08-01)

Natural history and progression of transthyretin amyloid cardiomyopathy: insights from ATTR‐ACT
by: Jose Nativi‐Nicolau, et al.
Published: (2021-10-01)

Clinical characteristics and natural history of wild‐type transthyretin amyloid cardiomyopathy in Japan
by: Toshihiro Yamada, et al.
Published: (2020-10-01)

Amyloid Cardiomyopathy in Hereditary Transthyretin V30M Amyloidosis - Impact of Sex and Amyloid Fibril Composition.
by: Sandra Arvidsson, et al.
Published: (2015-01-01)

NON-VAL30MET-TRANSTHYRETIN AMYLOID CARDIOMYOPATHY. LITERATURE REVIEW AND CLINICAL CASE
by: A. Ya. Gudkova, et al.
Published: (2018-03-01)

Selection of transthyretin amyloid inhibitors
by: Iakovleva, Irina
Published: (2016)

A machine learning model for identifying patients at risk for wild-type transthyretin amyloid cardiomyopathy
by: Ahsan Huda, et al.
Published: (2021-05-01)

Diagnostic algorithm in transthyretin amyloidosis with cardiomyopathy
by: Mariana Gospodinova, et al.
Published: (2020-07-01)

Molecular Aspects of Transthyretin Amyloid Disease
by: Sörgjerd, Karin
Published: (2008)

Characterizing the effect of transthyretin amyloid on the heart
by: Koch, Clarissa
Published: (2016)

Diagnosis of wild‐type transthyretin amyloid cardiomyopathy in Japan: red‐flag symptom clusters and diagnostic algorithm
by: Takayuki Inomata, et al.
Published: (2021-08-01)

Inhibition of Human Transthyretin Aggregation by Non-Steroidal Anti-Inflammatory Compounds: A Structural and Thermodynamic Analysis
by: Luis Mauricio T. R. Lima, et al.
Published: (2013-03-01)

Modulating factors in transthyretin/amyloid beta interaction
by: Carlos Alexandre Lopes Rodrigues Ribeiro
Published: (2019)

The progress in diagnosis and treatment of transthyretin amyloid polyneuropathy
by: ZHU Xi⁃ying, et al.
Published: (2021-06-01)

Mechanisms of Transthyretin Inhibition of IAPP AmyloidFormation
by: Sanduni Wasana Jayaweera, et al.
Published: (2021-03-01)

Structural Characterization of Cardiac Ex Vivo Transthyretin Amyloid: Insight into the Transthyretin Misfolding Pathway in Vivo
by: Dasari, Anvesh K. R., et al.
Published: (2021)

Establishment of an induced pluripotent stem cell line PUMCHi004-A from a hereditary transthyretin amyloid cardiomyopathy patient with transthyretin (TTR) p.Asp38Asn mutation
by: Shan He, et al.
Published: (2020-12-01)

Transthyretin microheterogeneity and molecular interactions: implications for amyloid formation
by: Landreh Michael, et al.
Published: (2014-06-01)

The role of non-coding genetic variants on transthyretin gene transcription in transthyretin amyloidosis
by: Boldbaatar, Batbold
Published: (2021)

Patient and family experience with transthyretin amyloid cardiomyopathy (ATTR-CM) and polyneuropathy (ATTR-PN) amyloidosis: results of two focus groups
by: David Rintell, et al.
Published: (2021-02-01)

Transthyretin-Related Familial Amyloid Polyneuropathy: In the Light of New Developments
by: Arman Çakar, et al.
Published: (2017-09-01)

Brazilian consensus for diagnosis, management and treatment of transthyretin familial amyloid polyneuropathy
by: Marcus Vinicius Pinto, et al.

Prefibrillar oligomeric Transthyretin mutants - amyloid conformation, toxicity and association with Serum amyloid P component
by: Andersson, Karin
Published: (2005)

Treatment With Tafamidis Slows Disease Progression in Early-Stage Transthyretin Cardiomyopathy
by: Marla B Sultan, et al.
Published: (2017-09-01)

Amyloid cardiomyopathy
by: Lucie Karafiatova, et al.
Published: (2017-06-01)

Clinical and genetic features of transthyretin-related familial amyloid polyneuropathy in China
by: Lei Liu, et al.
Published: (2020-11-01)

The Incremental Value of Diuretic Dose in Staging Systems for Transthyretin Cardiac Amyloid
by: Martha Grogan, MD
Published: (2020-09-01)

Impact of Non-Cardiac Clinicopathologic Characteristics on Survival in Transthyretin Amyloid Polyneuropathy
by: Alejandra González‐Duarte, et al.
Published: (2020-03-01)

Stochastic master equation for early protein aggregation in the transthyretin amyloid disease
by: Ruo-Nan Liu, et al.
Published: (2020-07-01)

A human antibody selective for transthyretin amyloid removes cardiac amyloid through phagocytic immune cells
by: Aubin Michalon, et al.
Published: (2021-05-01)

Oligomerization Profile of Human Transthyretin Variants with Distinct Amyloidogenicity
by: Ana Frangolho, et al.
Published: (2020-12-01)

Amyloid Cardiomyopathy: All that Sparkles is Amyloid
by: Abhinav Saxena, et al.
Published: (2016-01-01)